No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation

被引：0
|
作者：
Sachie Wada
Yuki Asano-Mori
Hisashi Yamamoto
Mitsuhiro Yuasa
Kosei Kageyama
Daisuke Kaji
Aya Nishida
Kazuya Ishiwata
Shinsuke Takagi
Go Yamamoto
Naoyuki Uchida
Akiko Yoneyama
Shigeyoshi Makino
Shuichi Taniguchi
机构：
[1] Toranomon Hospital,Department of Hematology
[2] Toranomon Hospital,Department of Clinical laboratory
[3] Toranomon Hospital,Department of Transfusion Medicine
来源：
Bone Marrow Transplantation | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：765 / 768
页数：3
相关论文
共 50 条
  • [21] PURE RED-CELL APLASIA OF LONG DURATION AFTER MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION
    VOLIN, L
    RUUTU, T
    ACTA HAEMATOLOGICA, 1990, 84 (04) : 195 - 197
  • [22] PURE RED-CELL APLASIA OF LONG DURATION COMPLICATING MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION
    GMUR, JP
    BURGER, J
    SCHAFFNER, A
    NEFTEL, K
    OELZ, O
    FREY, D
    METAXAS, M
    BLOOD, 1990, 75 (01) : 290 - 295
  • [23] Pure red cell aplasia (PRCA) following ABO-incompatible allogeneic bone marrow transplantation
    Sethi, S
    Hamadani, MH
    Kamble, R
    Kharfan-Dabaja, M
    Ozer, H
    Selby, GS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 38 - 38
  • [24] Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
    Lee, JH
    Lee, KH
    Kim, S
    Lee, JS
    Kim, SH
    Kwon, SW
    Kim, WK
    BONE MARROW TRANSPLANTATION, 2000, 25 (02) : 179 - 184
  • [25] Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
    J-H Lee
    K-H Lee
    S Kim
    J-S Lee
    S-H Kim
    S-W Kwon
    W-K Kim
    Bone Marrow Transplantation, 2000, 25 : 179 - 184
  • [26] Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation
    Fang, Baijun
    Song, Yongping
    Li, Ning
    Li, Jing
    Han, Qin
    Zhao, Robert Chunhua
    ANNALS OF HEMATOLOGY, 2009, 88 (03) : 261 - 266
  • [27] Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation
    Baijun Fang
    Yongping Song
    Ning Li
    Jing Li
    Qin Han
    Robert Chunhua Zhao
    Annals of Hematology, 2009, 88 : 261 - 266
  • [28] Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation
    Zhu, Kang-Er
    Li, Jun-Ping
    Zhang, Tao
    Zhong, Juan
    Chen, Jie
    HEMATOLOGY, 2007, 12 (02) : 117 - 121
  • [29] TREATMENT OF PURE RED-CELL APLASIA AFTER MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION RESISTANT TO ERYTHROPOIETIN
    OHASHI, K
    AKIYAMA, H
    TAKAMOTO, S
    TANIKAWA, S
    SAKAMAKI, H
    ONOZAWA, Y
    BONE MARROW TRANSPLANTATION, 1994, 13 (03) : 335 - 336
  • [30] TREATMENT OF PURE RED-CELL APLASIA AFTER MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION WITH RECOMBINANT ERYTHROPOIETIN
    HEYLL, A
    AUL, C
    RUNDE, V
    ARNING, M
    SCHNEIDER, W
    WERNET, P
    BLOOD, 1991, 77 (04) : 906 - 906
12345